This information is intended for Colorado Prescribers

HB 19-1131

MARKETED PRESCRIPTION DRUG

COLORADO WAC DISCLOSURE FORM

DATE UPDATED

Diabetes Products

Form

1/4/2022

Vaccines

Form

5/11/2022

ALDURAZYME® (laronidase)

Form

1/19/2022

ALPROLIX® [Coagulation factor IX (recombinant), Fc fusion protein]

Form

1/4/2022

AUBAGIO® (teriflunomide)

Form

1/4/2022

CABLIVI® (caplacizumab-yhdp)

Form

1/4/2022

CERDELGA® (eliglustat) capsules, for oral use

Form

1/19/2022

Cerezyme® (imiglucerase) for injection

Form

1/19/2022

DUPIXENT® (dupilumab) Injection

Form

4/3/2022

ELITEK® (rasburicase) for injection

Form

1/4/2022

ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]

Form

1/4/2022

ENJAYMO™ (sutimlimab-jome) injection, for intravenous use

Form

2/17/2022

FABRAZYME® (agalsidase beta) for injection, for intravenous use

Form

1/19/2022

JEVTANA® (cabazitaxel) Injection

Form

1/4/2022

KEVZARA® (sarilumab)

Form

1/4/2022

LEMTRADA® (alemtuzumab)

Form

1/4/2022

LIBTAYO® (cemiplimab - rwlc)

Form

5/13/2022

LOVENOX® (enoxaparin sodium injection) 

Form

1/19/2022

LUMIZYME® (alglucosidase alfa)

Form

1/19/2022

Mozobil® (plerixafor injection)

Form

1/4/2022

MULTAQ® (dronedarone)

Form

1/4/2022

NEXVIAZYME (avalglucosidase alfa-ngpt) for injection, for intravenous use

Form

1/19/2022

REZUROCK® (belumosudil) tablets

Form

5/1/2022

SARCLISA® (isatuximab-irfc) injection

Form

1/4/2022

Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]

Form

1/4/2022

THYROGEN® (thyrotropin alfa for injection)

Form

1/19/2022

House Bill 19-1131. Published by the General Assembly of the State of Colorado    

Please See Full Prescribing Information, including Boxed Warning, for AldurazymeAubagioElitekJevtanaKevzaraLemtradaLovenoxLumizymeMultaq,
 NexviazymeThymoglobulin
   

MAT-US-2007971-v5.0-05/2022
Last update: May 2022